Manufacturing Excellence
As a best-in-class global manufacturer with a strong focus on scalability and efficiency, we have the capacity to produce 25 billion finished doses annually across our six world-class manufacturing sites. Our global footprint also includes three world-class active pharmaceutical ingredients (API) manufacturing sites.
Investments of more than $1 billion within manufacturing and commercial operations, including capital equipment, along with strong commercial infrastructure and strategic expansions, have prepared us for our next phase of growth.
Patient safety and regulatory compliance guide every stage of our manufacturing process, ensuring our products always meet the quality and safety standards of global regulatory bodies.
Our strong focus on quality control and assurance ensures an uninterrupted supply to our customers and patients.
Research and development
New products are critical to our growth. We have invested over $2 billion in research and development in the past decade to improve everyday access to prescriptions and over-the-counter products. We launch more than 30 new products every year as a part of our commitment to supporting patients and consumers on their journey to health.
Quality assurance
Our experienced and knowledgeable quality assurance, regulatory, and compliance teams maintain the highest quality and safety standards.
Our best-in-class Health Canada, FDA, and other global regulatory approved manufacturing allows us to consistently deliver high-quality products - domestically by material production within Canada and through manufacturing and distribution facilities in India, Mexico and the United States.
